Skip to main content

Table 3 Diagnostic & Outcome Measures Definitionsa

From: Review of the current ongoing clinical trials exploring the possible anti-anxiety effects of cannabidiol

  1. aThis list is not exhaustive and is based on the most common outcome measures
  2. Table 3 was kindly provided by Syneos Health in an analysis of data from ClinicalTrials.gov, Biomedtracker, and PubMed, and particularly from the following references: (European Medicines Agency (EMA), 2006; Lecrubier et al., 2000; Stein & Stein, 2008)